Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
51 - 100 out of 274Page size: 50
Sort by: 1st author
  1. Published

    Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)

    Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, Agnete Witness Præst, Draghi, A., Theile, S., Madsen, K., Hasselby, Jane Preuss, Toxværd, A., Høgdall, Estrid Vilma Solyom, Lorentzen, T., Wilken, E. E., Geertsen, P., Svane, Inge Marie, Johansen, Julia Sidenius & Nielsen, D., 2023, In: European Journal of Cancer. 180, p. 125-133 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Randomized Phase II Study of Nivolumab with or Without Ipilimumab Combined with Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)

    Chen, I. M., Johansen, Julia Sidenius, Theile, S., Hjaltelin, Jessica Xin, Novitski, Sif Ingibergsdóttir, Brunak, Søren, Hasselby, Jane Preuss, Willemoe, G. L., Lorentzen, T., Madsen, K., Jensen, B. V., Wilken, E. E., Geertsen, P., Behrens, C., Nolsøe, Christian, Hermann, K. L., Svane, Inge Marie & Nielsen, Dorte Lisbet, 2022, In: Journal of Clinical Oncology. 40, 27, p. 3180-3189

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road

    Crowther, M. D., Svane, Inge Marie & Met, Özcan, 2020, In: Cells. 9, 7, 18 p., 1588.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

    Crowther, M. D., Dolton, G., Legut, M., Caillaud, M. E., Lloyd, A., Attaf, M., Galloway, S. A. E., Rius, C., Farrell, C. P., Szomolay, B., Ager, A., Parker, A. L., Fuller, A., dqp123, dqp123, McCluskey, J., Rossjohn, J., Svane, Inge Marie, Phillips, J. D. & Sewell, A. K., 2020, In: Nature Immunology. 21, 2, p. 178-185 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

    Dafni, U., Michielin, O., Lluesma, S. M., Tsourti, Z., Polydoropoulou, V., Karlis, D., Besser, M. J., Haanen, J., Svane, Inge Marie, Ohashi, P. S., Kammula, U. S., Orcurto, A., Zimmermann, S., Trueb, L., Klebanoff, C. A., Lotze, M. T., Kandalaft, L. E. & Coukos, G., 2019, In: Annals of Oncology. 30, 12, p. 1902-1913 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply

    Dahl, E., Abed, O., Agnholt, J., Bjerrum, Jakob Tveiten , Dige, A., Kjeldsen, J., Svane, Inge Marie, Donia, M. & Seidelin, Jakob Benedict, 2023, In: Alimentary Pharmacology and Therapeutics. 57, 8, p. 918-919

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  7. Published

    Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply

    Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 152-153 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  8. Published

    Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis

    Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, 2022, In: Alimentary Pharmacology and Therapeutics. 56, 9, p. 1370-1382 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy

    Dolton, G., Rius, C., Wall, A., Szomolay, B., Bianchi, V., Galloway, S. A. E., Hasan, M. S., Morin, T., Caillaud, M. E., Thomas, H. L., Theaker, S., Tan, L. R., Fuller, A., Topley, K., Legut, M., Attaf, M., Hopkins, J. R., Behiry, E., Zabkiewicz, J., Alvares, C. & 13 others, Lloyd, A., Rogers, A., Henley, P., Fegan, C., Ottmann, O., Man, S., Crowther, M. D., Donia, M., Svane, Inge Marie, Cole, D. K., Brown, P. E., Rizkallah, P. & Sewell, A. K., 2023, In: Cell. 186, 16, p. 3333-3349.e27 45 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers

    Dolton, G., Tungatt, K., Lloyd, A., Bianchi, V., Theaker, S. M., Trimby, A., Holland, C. J., Donia, M., Godkin, A. J., Cole, D. K., Straten, P. T., Peakman, M., Svane, Inge Marie & Sewell, A. K., Sep 2015, In: Immunology. 146, 1, p. 11-22 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  11. Published

    Cancer immunotherapy in patients with preexisting autoimmune disorders

    dqp123, dqp123, Pedersen, M. & Svane, Inge Marie, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 333-337 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  12. Published

    The real-world impact of modern treatments on the survival of patients with metastatic melanoma

    dqp123, dqp123, Ellebaek, E., Øllegaard, T. H., Duval, L., Aaby, J. B., Hoejberg, L., Køhler, U. H., Schmidt, H., Bastholt, L. & Svane, Inge Marie, 2019, In: European Journal of Cancer. 108, p. 25-32 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials

    dqp123, dqp123, Kimper-Karl, M. L., Høyer, K. L., Bastholt, L., Schmidt, H. & Svane, Inge Marie, 2017, In: European Journal of Cancer. 74, p. 89-95

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

    Donia, M., Ellebaek, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2012, In: OncoImmunology. 1, 8, p. 1297-1304 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    IFN-γ to improve immunotherapy for melanoma

    Donia, M., Svane, Inge Marie, Andersen, M. H., Hansen, M., Straten, P. T., Ellebæk, E., Iversen, T. Z. & SL, S., 2012. 0 p.

    Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

  16. Published

    Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity

    Donia, M., Andersen, R., Kjeldsen, J. W., Fagone, P., Munir, S., Nicoletti, F., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 15 Sep 2015, In: Cancer Research. 75, 18, p. 3747-59 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    The controversial role of TNF in melanoma

    Donia, M., Kjeldsen, J. W. & Svane, Inge Marie, 2016, In: OncoImmunology. 5, 4, 2 p., e1107699.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  18. Published

    PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer

    dqp123, dqp123, Kjeldsen, J. W., Andersen, R., Westergaard, M. C. W., Bianchi, V., Legut, M., Attaf, M., Szomolay, B., Ott, S., Dolton, G., Lyngaa, R., Hadrup, S. R., Sewell, A. K. & Svane, Inge Marie, 2017, In: Clinical Cancer Research. 23, 19, p. 5779-5788

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Characterization and comparison of "Standard" and "Young" tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution

    Donia, M., Junker, N., Ellebaek, E., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2012, In: Scandinavian Journal of Immunology. 75, 2, p. 157-167 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

    Donia, M., Fagone, P., Nicoletti, F., Andersen, R. S., Høgdall, E., Straten, P. T., Andersen, M. H. & Svane, Inge Marie, 2012, In: OncoImmunology. 1, 9, p. 1476-1483 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion

    Donia, M., Hansen, M., Sendrup, S. L., Iversen, T. Z., Ellebæk, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2013, In: Journal of Investigative Dermatology. 133, 2, p. 545-52 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

    Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, Seliger, B., Jönsson, G. & Svane, Inge Marie, 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor

    Donia, M., Larsen, S. M., Met, Özcan & Svane, Inge Marie, Aug 2014, In: Cytotherapy. 16, 8, p. 1117–1120 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Real-world evidence to guide healthcare policies in oncology

    dqp123, dqp123, Hansen, S. W. & Svane, Inge Marie, 2019, In: OncoTarget. 10, 44, p. 4513-4515

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNϒ, Following Recognition of Autologous Tumor-Antigens

    Draghi, A., Chamberlain, C. A., Khan, S., Papp, K., Lauss, M., Soraggi, S., Radic, H. D., Presti, M., Harbst, K., Gokuldass, A., Kverneland, Anders Handrup, Nielsen, M., Westergaard, M. C. W., Andersen, Mads Hald, Csabai, I., Jönsson, G., Szallasi, Z., Svane, Inge Marie & dqp123, dqp123, 2021, In: Frontiers in Immunology. 12, 13 p., 705422.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Uncoupling CD4þ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

    Draghi, A., Presti, M., Jensen, A. W. P., Chamberlain, C. A., Albieri, B., Rasmussen, A. C. K., Andersen, M. H., Crowther, M. D., Svane, Inge Marie & Donia, M., 1 Oct 2023, In: Clinical Cancer Research. 29, 19, p. 3937-3947 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs

    Draghi, A., Borch, T. H., Radic, H. D., Chamberlain, C. A., Gokuldass, A., Svane, Inge Marie & dqp123, dqp123, 2019, In: International Journal of Cancer. 145, 5, p. 1408-1413 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

    Duraiswamy, J., Turrini, R., Minasyan, A., Barras, D., Crespo, I., Grimm, A. J., Casado, J., Genolet, R., Benedetti, F., Wicky, A., Ioannidou, K., Castro, W., Neal, C., Moriot, A., Renaud-Tissot, S., Anstett, V., Fahr, N., Tanyi, J. L., Eiva, M. A., Jacobson, C. A. & 16 others, Montone, K. T., Westergaard, M. C. W., Svane, Inge Marie, Kandalaft, L. E., Delorenzi, M., Sorger, P. K., Färkkilä, A., Michielin, O., Zoete, V., Carmona, S. J., Foukas, P. G., Powell, D. J., Rusakiewicz, S., Doucey, M. A., Dangaj Laniti, D. & Coukos, G., 2021, In: Cancer Cell. 39, 12, p. 1623-1642.e20

    Research output: Contribution to journal › Journal article › Research › peer-review

  29. Published

    Immune checkpoint inhibitor treatment and ophthalmologist consultations in patients with malignant melanoma or lung cancer—A nationwide cohort study

    D’Souza, M., Bagger, M., Alberti, M., Malmborg, M., Schou, Morten, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar, Svane, Inge Marie & Kiilgaard, Jens Folke, 1 Jan 2022, In: Cancers. 14, 1, 13 p., 49.

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer

    D’souza, M., Svane, Inge Marie, Gislason, Gunnar Hilmar & Schou, Morten, 21 Apr 2021, In: European Heart Journal. 42, 16, p. 1636-1636 1 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  31. Published

    The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study

    D’souza, M., Nielsen, Dorte Lisbet, Svane, Inge Marie, Iversen, Kasper, Rasmussen, P. V., Madelaire, C., Fosbøl, E., Køber, Lars Valeur, Gustafsson, Finn, Andersson, C., Gislason, Gunnar Hilmar, Torp-Pedersen, Christian & Schou, Morten, 2021, In: European Heart Journal. 42, 16, p. 1621-1631

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Accepted/In press

    “One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care

    Egeler, M. D., Boomstra, E., Rohaan, M. W., Van den Heuvel, N. M. J., Fraterman, I., Delfos, M., van de Poll-Franse, L. V., Borch, T. H., Svane, Inge Marie, Haanen, J. B. A. G., Retèl, V. P. & Boekhout, A. H., 2024, (Accepted/In press) In: Journal of Cancer Survivorship.

    Research output: Contribution to journal › Journal article › Research › peer-review

  33. Published

    Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

    Eggermont, A. M. M., Meshcheryakov, A., Atkinson, V., Blank, C. U., Mandala, M., Long, G. V., Barrow, C., Di Giacomo, A. M., Fisher, R., Sandhu, S., Kudchadkar, R., Romero, P. L. O., Svane, I. M., Larkin, J., Puig, S., Hersey, P., Quaglino, P., Queirolo, P., Stroyakovskiy, D., Bastholt, L. & 14 others, Mohr, P., Hernberg, M., Chiarion-Sileni, V., Strother, M., Hauschild, A., Yamazaki, N., van Akkooi, A. C., Lorigan, P., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S. & Robert, C., 2021, In: European Journal of Cancer. 158, p. 156-168 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous

    Ellebaek, E., Bastholt, L., Schmidt, H., Svane, Inge Marie & dqp123, dqp123, 1 Dec 2019, In: International Journal of Cancer. 145, 11, p. 3173-3174 2 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  35. Published

    Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

    Ellebaek, E., Iversen, T. Z., Junker, N., Donia, M., Engell-Noerregaard, L., Met, Özcan, Hølmich, Lisbet Rosenkrantz, Andersen, R. S., Hadrup, S. R., Andersen, M. H., Thor Straten, P. & Svane, Inge Marie, 2012, In: Journal of Translational Medicine. 10, p. 169

    Research output: Contribution to journal › Journal article › Research › peer-review

  36. Published

    Immunotherapy for metastatic colorectal cancer: Present status and new options

    Ellebaek, E., Andersen, M. H., Svane, Inge Marie & Straten, P. T., 2012, In: Scandinavian Journal of Gastroenterology. 47, 3, p. 315-24 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma

    Ellebaek, E., Schina, A., Andersen, R., Hendel, Helle Westergren, Svane, Inge Marie & dqp123, dqp123, 2022, In: International Journal of Cancer. 150, 11, p. 1870-1878 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. Published

    The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients

    Ellebaek, E., Svane, Inge Marie, Schmidt, H., Haslund, C. A., dqp123, dqp123, Hoejberg, L., Ruhlmann, C., Guldbrandt, L. M., Køhler, U. H. & Bastholt, L., Aug 2021, In: Cancer Epidemiology. 73, 7 p., 101943.

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Seasonal variation in effect of anti-PD-1 initiation on overall survival among patients with advanced melanoma

    Ellebaek, E., Schina, A., Schmidt, H., Haslund, C. A., Bastholt, L., Svane, Inge Marie & dqp123, dqp123, 2023, In: Pigment Cell and Melanoma Research. 36, 2, p. 224-231

    Research output: Contribution to journal › Journal article › Research › peer-review

  40. Published

    Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

    Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Moerch Froesig, T., Munir, S., Hadrup, S. R., Andersen, M. H. & Svane, Inge Marie, 2012, In: Cancer Immunology, Immunotherapy. 61, 10, p. 1791-1804 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  41. Published

    Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

    Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  42. Published

    Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma

    Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  43. Published

    FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma

    Engell-Noerregaard, L., Hendel, H. W., Johannesen, H. H., Alslev, L. & Svane, Inge Marie, 2013, In: Cancer Immunology, Immunotherapy. 62, 1, p. 17-25 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

    Engell-Noerregaard, L., Hansen, T. H., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 2009, In: Cancer Immunology, Immunotherapy. 58, 1, p. 1-14 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  45. Published

    KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

    Ferrucci, P. F., Di Giacomo, A. M., Del Vecchio, M., Atkinson, V., Schmidt, H., Schachter, J., Queirolo, P., Long, G. V., Stephens, R., Svane, Inge Marie, Lotem, M., Abu-Amna, M., Gasal, E., Ghori, R., Diede, S. J., Croydon, E. S., Ribas, A., Ascierto, P. A. & KEYNOTE-022 international team, K. I. T., 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 8 p., e001806.

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Comparison of efficacy in patients with metastatic melanoma treated with ipilimumab and nivolumab who did or did not discontinue treatment due to immune-related adverse events: A real-world data study

    Fink, M., Vittrup, A. S., Bastholt, L., Svane, Inge Marie, dqp123, dqp123, Luczak, A. A., Ruhlmann, C. H., Guldbrandt, L. M., Koehler, U. H., Winther, M. L., Ellebaek, E., Haslund, C. A. & Schmidt, H., 2021, In: Cancers. 13, 21, 10 p., 5550.

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Immuncheckpointantistoffer øger overlevelsen for patienter med metastatisk melanom

    Fløe, L. E., Svane, Inge Marie, Bastholt, L. & Schmidt, H., 2016, In: Ugeskrift for Laeger. 178, 4 p., V01160070.

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy–resistant human melanoma in IL2 transgenic NOD/SCID IL2 receptor knockout mice

    Forsberg, E. M. V., Lindberg, M. F., Jespersen, H., Alsen, S., Bagge, R. O., dqp123, dqp123, Svane, Inge Marie, Nilsson, O., Ny, L., Nilsson, L. M. & Nilsson, J. A., 2019, In: Cancer Research. 79, 5, p. 899-904 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  49. Published

    CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer

    Friese, C., Harbst, K., Borch, T. H., Westergaard, M. C. W., Pedersen, M., Kverneland, A., Jönsson, G., dqp123, dqp123, Svane, Inge Marie & Met, Özcan, 2020, In: Scientific Reports. 10, 1, 12 p., 3914.

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05

    Frøsig, T. M., Yap, J., Seremet, T., Lyngaa, R., Svane, Inge Marie, Thor Straten, P., Heemskerk, M. H. M., Grotenbreg, G. M. & Hadrup, S. R., Oct 2015, In: Cytometry. Part A. 87, 10, p. 967-75 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next

ID: 4054758